These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 17331619

  • 1. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
    Cirioni O, Giacometti A, Kamysz W, Silvestri C, Riva A, Della Vittoria A, Abbruzzetti A, Lukasiak J, Scalise G.
    Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
    Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, Cirioni O, Gabrielli E, Lenci I, Kamysz W, Kamysz E, Giacometti A, Scalise G, Barchiesi F, Offidani A.
    Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
    Pankey GA, Ashcraft DS.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.
    Jorge P, Grzywacz D, Kamysz W, Lourenço A, Pereira MO.
    PLoS One; 2017 Jul; 12(3):e0174654. PubMed ID: 28355248
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
    Oo TZ, Cole N, Garthwaite L, Willcox MD, Zhu H.
    J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY, Ko KS, Song JH, Peck KR.
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
    Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ.
    J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
    [Abstract] [Full Text] [Related]

  • 17. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.
    Maisetta G, Mangoni ML, Esin S, Pichierri G, Capria AL, Brancatisano FL, Di Luca M, Barnini S, Barra D, Campa M, Batoni G.
    Peptides; 2009 Sep; 30(9):1622-6. PubMed ID: 19520127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
    Giacometti A, Cirioni O, Kamysz W, Silvestri C, Licci A, Riva A, Łukasiak J, Scalise G.
    Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.